Track the Chromocell Therapeutics Corp share price and the full directors' dealings record of the company, a listed equity based in United States. Shares are quoted on the US market, under the supervision of SEC (Form 4). The latest transaction was reported on 16 September 2024 (Acquisition). Among the most active insiders: Francis Knuettel II. All data is openly available.
7
Insider Decl.
n/a
Thresholds
€108,088
4 ops.
Buy Volume
n/a
n/a
Sell Volume
46Σ signal
Buys €108,088n/a Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
29,167 shares@ US$4.80100.0% of flowCommon StockSEC:0001753926-24-000374:0
7 of 7 declarations
About Chromocell Therapeutics Corp
Chromocell Therapeutics Corp is a company focused on developing innovative therapies based on biotechnology. It concentrates on the discovery and commercialization of treatments for serious diseases.